Your browser doesn't support javascript.
loading
Towards More Predictive, Physiological and Animal-free In Vitro Models: Advances in Cell and Tissue Culture 2020 Conference Proceedings.
Singh, Bhumika; Abdelgawad, Mohamed Essameldin; Ali, Zulfiqur; Bailey, Jarrod; Budyn, Elisa; Civita, Prospero; Clift, Martin J D; Connelly, John T; Constant, Samuel; Hittinger, Marius; Kandarova, Helena; Kearns, Victoria Rosalind; Kiuru, Tony; Kostrzewski, Tomasz; Kress, Sebastian; Durban, Victoria Marsh; Lehr, Claus-Michael; McMillan, Hayley; Metz, Julia Katharina; Monteban, Vivian; Movia, Dania; Neto, Catia; Owen, Carla; Paasonen, Lauri; Palmer, Kerri Anne; Pilkington, Geoffrey John; Pilkington, Karen; Prina-Mello, Adriele; Roper, Clive; Sheard, Jonathan; Smith, Sheree; Turner, Janette Ellen; Roy, Ipsita; Tutty, Melissa Anne; Velliou, Eirini; Wilkinson, John Malcolm.
Affiliation
  • Singh B; Kirkstall Ltd, York, UK.
  • Abdelgawad ME; Cellular, Molecular & Industrial Biotechnology and Cellular & Molecular Immunobiology, Faculty of Science, Helwan University, Cairo, Egypt.
  • Ali Z; Healthcare Innovation Centre, School of Health and Life Sciences, Teesside University, Middlesbrough, UK.
  • Bailey J; Center for Contemporary Sciences, Gaithersburg, MD, USA.
  • Budyn E; CNRS Laboratory of Mechanics and Technology, Ecole Normale Superieure Paris-Saclay, University Paris-Saclay, Gif-sur-Yvette, France.
  • Civita P; Brain Tumour Research Centre, Institute of Biological and Biomedical Sciences (IBBS), School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
  • Clift MJD; School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.
  • Connelly JT; In Vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Swansea, UK.
  • Constant S; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Hittinger M; Epithelix, Geneva, Switzerland.
  • Kandarova H; Pharmbiotec Research and Development GmbH, Saarbrücken, Germany.
  • Kearns VR; Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Kiuru T; Department of Eye and Vision Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Kostrzewski T; UPM-Kymmene Corporation, Helsinki, Finland.
  • Kress S; CN Bio Innovations, Cambridge, UK.
  • Durban VM; Department of Biotechnology, Institute for Cell and Tissue Culture Technologies, University of Natural Resources and Life Sciences, Vienna, Austria.
  • Lehr CM; Cellesce Limited, Cardiff, UK.
  • McMillan H; Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), and Saarland University, Saarbrücken, Germany.
  • Metz JK; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Monteban V; Pharmbiotec Research and Development GmbH, Saarbrücken, Germany.
  • Movia D; Department of Pharmacy, Saarland University, Saarbrücken, Germany.
  • Neto C; SABEU GmbH & Co. KG, Northeim, Germany.
  • Owen C; Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
  • Paasonen L; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
  • Palmer KA; Animal Free Research UK, London, UK.
  • Pilkington GJ; UPM-Kymmene Corporation, Helsinki, Finland.
  • Pilkington K; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK.
  • Prina-Mello A; School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
  • Roper C; School of Health and Social Care Professions, Faculty of Health and Science, University of Portsmouth, Portsmouth, UK.
  • Sheard J; Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
  • Smith S; Roper Toxicology Consulting Limited, Edinburgh, UK.
  • Turner JE; UPM-Kymmene Corporation, Helsinki, Finland.
  • Roy I; School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, UK.
  • Tutty MA; Safer Medicines, London, UK.
  • Velliou E; Department of Materials Science & Engineering, Kroto Research Institute, University of Sheffield, Sheffield, UK.
  • Wilkinson JM; Trinity Centre for Health Sciences, Trinity College Dublin, The University of Dublin, Dublin, Ireland.
Altern Lab Anim ; 49(3): 93-110, 2021 May.
Article in En | MEDLINE | ID: mdl-34225465
ABSTRACT
Experimental systems that faithfully replicate human physiology at cellular, tissue and organ level are crucial to the development of efficacious and safe therapies with high success rates and low cost. The development of such systems is challenging and requires skills, expertise and inputs from a diverse range of experts, such as biologists, physicists, engineers, clinicians and regulatory bodies. Kirkstall Limited, a biotechnology company based in York, UK, organised the annual conference, Advances in Cell and Tissue Culture (ACTC), which brought together people having a variety of expertise and interests, to present and discuss the latest developments in the field of cell and tissue culture and in vitro modelling. The conference has also been influential in engaging animal welfare organisations in the promotion of research, collaborative projects and funding opportunities. This report describes the proceedings of the latest ACTC conference, which was held virtually on 30th September and 1st October 2020, and included sessions on in vitro models in the following areas advanced skin and respiratory models, neurological disease, cancer research, advanced models including 3-D, fluid flow and co-cultures, diabetes and other age-related disorders, and animal-free research. The roundtable session on the second day was very interactive and drew huge interest, with intriguing discussion taking place among all participants on the theme of replacement of animal models of disease.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin / Lab-On-A-Chip Devices Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Altern Lab Anim Year: 2021 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin / Lab-On-A-Chip Devices Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Altern Lab Anim Year: 2021 Type: Article Affiliation country: United kingdom